Daniel Weiner

Daniel Weiner

Net worth: 302 976 $ as of 2026-06-29

76 year
Technology Services
Consumer Services
Health Technology

Profile

Daniel L.
Weiner
is the founder of Statistical Consultants, Inc. Current positions include Chairman at Simulations Plus, Inc. since 2024, Professor at the University of Maryland School of Pharmacy, and Professor at UNC Eshelman School of Pharmacy.
Former positions include Independent Director at DILIsym Services, Inc., SVP & Head-Global Clinical Development at IVAX LLC from 2003 to 2004, Chief Technology Officer & Senior Vice President at Pharsight Corp., Senior Vice President-Software Development at Pharsight Corp.
from 1998 to 2002, Senior Vice President & Principal Scientist at Quintiles, Inc. (California), Head-Biostatistics at Merrell Dow Pharmaceuticals, Inc., Vice President at Syntex Development Research, and Chief Technology Officer & Senior Vice President at Certara USA, Inc. Education includes undergraduate, graduate, and doctorate degrees from the University of Kentucky.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-30 16,547 ( 0.08% ) 302 976 $ 2026-06-29

Daniel Weiner active positions

CompaniesPositionStart
SIMULATIONS PLUS, INC. Chairman 2024-12-16
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Daniel Weiner

CompaniesPositionEnd
Director/Board Member 2021-08-31
Chief Tech/Sci/R&D Officer 2004-04-30
Corporate Officer/Principal 2002-11-30
Chief Tech/Sci/R&D Officer -
Corporate Officer/Principal -
See the detail of Daniel Weiner's experience

Training of Daniel Weiner

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

19

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Health Technology

Technology Services

Technology Services

Health Services

Consumer Services

Merrell Dow Pharmaceuticals, Inc.

Statistical Consultants, Inc.

Syntex Development Research

Commercial Services

Consumer Services

Consumer Services

Technology Services